Sales 2024 * | 43.06M 31.48M | Sales 2025 * | 58.43M 42.71M | Capitalization | 32.34M 23.64M |
---|---|---|---|---|---|
Net income 2024 * | -7M -5.12M | Net income 2025 * | -1M -731K | EV / Sales 2024 * | 0.75 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.55 x |
P/E ratio 2024 * |
-5.33
x | P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.53% |
Latest transcript on Medipharm Labs Corp
Managers | Title | Age | Since |
---|---|---|---|
David Pidduck
CEO | Chief Executive Officer | - | 22-04-19 |
Greg Hunter
DFI | Director of Finance/CFO | - | 21-02-07 |
Keith Strachan
PSD | President | - | 18-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Bumby
BRD | Director/Board Member | 60 | 23-03-31 |
David Pidduck
CEO | Chief Executive Officer | - | 22-04-19 |
Shelley Martin
BRD | Director/Board Member | - | 20-06-21 |
1st Jan change | Capi. | |
---|---|---|
+40.09% | 6.16B | |
-16.34% | 4.46B | |
-7.11% | 3.27B | |
+5.14% | 3.2B | |
-0.18% | 2.6B | |
+47.93% | 1.98B | |
-7.15% | 1.7B | |
+0.67% | 1.66B | |
-8.73% | 1.61B |